BackPyxis Oncology Overview

Pyxis Oncology Receivables

Track Pyxis Oncology's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
100.00% YoYΔ $-3.00M vs prior year quarter

Peer trimmed avg / median

Loading

Pyxis Oncology Receivables History

Loading

Pyxis Oncology vs. peers: Receivables Comparison

Loading

Pyxis Oncology Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pyxis Oncology (PYXS) FAQ

The latest receivables for PYXS is $0 as of June 2026. That compares with $3M in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Pyxis Oncology's historical trend and sector peers before judging valuation or financial health.

Over the past year, PYXS's receivables moved from $3M to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pyxis Oncology's operating scale or balance-sheet position.

A receivables figure of $0 for PYXS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PYXS's receivables ($0), review year-over-year change from $3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Pyxis Oncology's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.